Skip to content
‹ Back to IndustriesHealthcare

Cut Through the Chaos of Review Processes in Healthcare: Implement a Reference Guide for Annotations

Annalise Ludtke and Elizabeth Calderon discuss strategies to improve healthcare promotional review processes. They emphasize creating a reference guide for annotations and using historical data to streamline workflow. Their insights aim to enhance efficiency and collaboration in material reviews.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Vodori on MarketScale.

By Annalise Ludtke · AnnotationElizabeth CalderonMlr ReviewPromotional Review Processes
Share
Cut Through the Chaos of Review Processes in Healthcare: Implement a Reference Guide for Annotations

Key takeaways

01

Implementing a reference guide for annotations can improve review processes.

02

Using annotation colors and clear guidelines reduces misunderstandings.

03

Leveraging historical data identifies training opportunities for teams.

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI in a free MarketScale workspace. Qualifying companies also get one professional video edit a month. No credit card.

Start free

In an era where organizations are compelled to do more with less, Vodori's latest episode of the Benchmarks Symposium sheds light on optimizing promotional review processes. Hosted by Annalise Ludtke, the Senior Manager of Marketing and Communications at Vodori, the video features insights from Elizabeth Calderon, a seasoned Customer Success Manager at Vodori. They delve into the 2023 State of Promotional Review Benchmarks Report, offering valuable best practices for overcoming resource constraints and enhancing efficiency.

The conversation focuses on the challenges organizations face, such as limited budgets and increased pressure to perform. Elizabeth shares practical advice based on her direct experience working with customers, highlighting the creation of a reference guide for annotations as a key strategy for improving review processes. This guide helps align reviewers and initiators, streamlining the review process and reducing misunderstandings. Elizabeth's tips on using annotation colors for quick identification and establishing clear guidelines for replying to annotations further illustrate how simple, actionable changes can significantly impact efficiency and effectiveness.

This guide helps align reviewers and initiators, streamlining the review process and reducing misunderstandings.

Moreover, the episode explores how leveraging historical data on annotations can identify common pitfalls and training opportunities, thereby improving the quality of submissions and reducing review times. This approach not only enhances the promotional review process but also fosters better collaboration between teams, including marketing, regulatory reviewers, and agencies.

Vodori

Part of this channel

Vodori

Faster market access through compliant life science content review.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

AL
Annalise Ludtke
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0. No credit card. Company confirmation required.

More Healthcare Insights

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raises CAD $4.24M to expand its LLM-guided specialty care workflows

Blair Health raised CAD $4.24 million in a pre-seed round, according to Fierce Healthcare. It plans to expand protocol-driven virtual specialty care across Canada and the U.S.

  • 01Blair Health raised CAD $4.24 million in pre-seed funding.
  • 02Qualified Health positions its AI platform around safety and governance, including clinician oversight, auditability and traceability, according to Fierce Healthcare.

Sep 23, 2026

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Experts

AL
Annalise Ludtke

Senior Manager of Marketing and Communications at Vodori

Annalise Ludtke is the Senior Manager of Marketing and Communications at Vodori. She hosts discussions on optimizing promotional review processes. Annalise delves into challenges organizations face and offers strategies to improve efficiency.

EC
Elizabeth Calderon

Customer Success Manager

Vodori

Elizabeth Calderon is a seasoned Customer Success Manager at Vodori. She provides insights into the challenges of review processes and offers practical advice from her direct experience working with customers.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512